Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9725714 Compositions and methods of nucleic acid-targeting nucleic acids

Patent 9725714 was granted and assigned to Caribou Biosciences on August, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Caribou Biosciences

Current Assignee

Caribou Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

97257140

Patent Inventor Names

James M. Berger0

Jennifer A. Doudna0

Matthew Merrill Carter0

Paul Daniel Donohoue0

Rachel E. Haurwitz0

Andrew Paul May0

Date of Patent

August 8, 2017

Patent Application Number

151596190

Date Filed

May 19, 2016

Patent Citations Received

‌

US Patent 12110545 Methods of assessing nuclease cleavage

‌

US Patent 11661599 CRISPR-Cas based system for targeting single-stranded sequences

‌

US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing

‌

US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing

‌

US Patent 11866726 Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites

‌

US Patent 11911415 CRISPR/Cas-related methods and compositions for improving transplantation

Patent Primary Examiner

‌

Jim Ketter

Patent abstract

This disclosure provides for compositions and methods for the use of nucleic acid-targeting nucleic acids and complexes thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9725714 Compositions and methods of nucleic acid-targeting nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API